We are live on ! Find out more
STAA icon

STAAR Surgical

212 hedge funds and large institutions have $1.18B invested in STAAR Surgical in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 74 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 74

1.95% less ownership

Funds ownership: 100.15%98.2% (-1.9%)

10% less funds holding

Funds holding: 236212 (-24)

36% less capital invested

Capital invested by funds: $1.83B → $1.18B (-$655M)

42% less call options, than puts

Call options by funds: $2.4M | Put options by funds: $4.12M

42% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 50

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
212
Holders Change
-24
Holders Change %
-10.17%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
76
Reduced
74
Closed
50
Calls
$2.4M
Puts
$4.12M
Net Calls
-$1.73M
Net Calls Change
-$10.3M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
1
Broadwood Capital
New York
$264M +$2.29M +80,200 +0.7%
BlackRock
2
BlackRock
New York
$200M +$16.6M +582,426 +8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$142M +$9.12M +319,441 +6%
State Street
4
State Street
Massachusetts
$49.9M +$3.2M +112,207 +6%
RAM
5
Resona Asset Management
Japan
$36.4M +$13.8M +482,726 +47%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$28.5M +$6.08K +213 +0%
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$28M -$8.76M -306,599 -21%
AC
8
Armistice Capital
New York
$21.2M +$10.7M +375,500 +76%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$20.7M +$4.88M +171,046 +25%
ACM
10
American Capital Management
New York
$20.6M +$9.58M +335,603 +65%
Morgan Stanley
11
Morgan Stanley
New York
$19.6M -$1.02M -35,827 -4%
YC
12
Yunqi Capital
Hong Kong
$18.6M +$7.2M +252,113 +49%
Millennium Management
13
Millennium Management
New York
$18.4M -$2.37M -83,079 -10%
DC
14
Defender Capital
North Carolina
$17M +$684K +23,950 +4%
GCM
15
Geneva Capital Management
Wisconsin
$16.1M -$931K -32,590 -5%
Northern Trust
16
Northern Trust
Illinois
$12.7M -$3.02M -105,846 -17%
PAI
17
Palo Alto Investors
California
$12.2M -$16.9M -590,833 -54%
Charles Schwab
18
Charles Schwab
California
$10.8M +$519K +18,168 +4%
Bank of America
19
Bank of America
North Carolina
$10.7M -$1.5M -52,467 -11%
Artisan Partners
20
Artisan Partners
Wisconsin
$10.7M -$321K -11,236 -2%
Goldman Sachs
21
Goldman Sachs
New York
$9.92M +$3.86M +135,339 +50%
JAM
22
Jupiter Asset Management
United Kingdom
$9.16M +$2.89M +101,373 +37%
Citadel Advisors
23
Citadel Advisors
Florida
$7.81M -$17.5M -612,804 -66%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$7.66M -$689K -24,136 -7%
Ensign Peak Advisors
25
Ensign Peak Advisors
Utah
$7.54M -$6.25M -218,949 -41%

STAA Hedge Fund Activity: Q4 2024 in Review

212 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2024, worth a combined $1.18B — down 36% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of STAA and 29 opened new positions — a net loss of 21 holders — while 74 trimmed existing stakes and 76 added.

The largest buyer was BlackRock, adding an estimated $16.6M. The largest seller was Citadel Advisors, cutting an estimated $17.5M.

  • 212 institutional investors held STAAR Surgical (STAA) as of Q4 2024, down from 236 in Q3 2024.
  • Funds reported $1.18B of STAAR Surgical stock for Q4 2024, down 36% quarter-over-quarter.
  • 29 funds opened new STAAR Surgical positions in Q4 2024 and 50 closed out, a net change of -21 holders.
  • The largest STAAR Surgical buyer in Q4 2024 was BlackRock, an estimated $16.6M added.
  • The largest STAAR Surgical seller in Q4 2024 was Citadel Advisors, an estimated $17.5M sold.

Based on aggregated 13F filings for Q4 2024.